Coronavirus Update: J&J Highlights Positive Booster Shot Data
Japan Withdraws Moderna Lots
Also, Moderna completed the submission of the BLA for mRNA-1273’s FDA approval, Pfizer starts a rolling submission for a booster shot and Brii Biosciences announced data for its two-antibody antiviral cocktail, and Japan withdraws selected lots of Moderna's vaccine over contamination worries.
You may also be interested in...
Takeda and Moderna have identified the source of metallic particles in some lots of mRNA-1273 in Japan, but believe the two deaths identified to be coincidental. Pfizer starts protease inhibitor trial, and Rigel reports fostamatinib data.
Government and companies conducting urgent investigation into two deaths in recipients of Moderna vaccine, the causes of which remain unclear at this stage.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker